Annotation Detail

Information
Associated Genes
NF1
Associated Variants
NF1 MUTATION
NF1 MUTATION
Associated Disease
plexiform neurofibroma
Source Database
CIViC Evidence
Description
Treatment with selumetinib (NCT01362803) resulted in confirmed partial, long term responses in 17 of the 24 children with NF1 associated plexiform fibromas (71%) and decreases from baseline in neurofibroma volume in 12 of 18 mice (67%).
Variant Origin
germline
Variant Origin
Rare Germline
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/1958
Gene URL
https://civic.genome.wustl.edu/links/genes/3867
Variant URL
https://civic.genome.wustl.edu/links/variants/587
Rating
3
Evidence Type
Predictive
Disease
Plexiform Neurofibroma
Evidence Direction
Supports
Drug
Selumetinib
Evidence Level
B
Clinical Significance
Sensitivity/Response
Pubmed
28029918
Drugs
Drug NameSensitivitySupported
SelumetinibSensitivitytrue